Global Insomnia Market|| keyplayers Merck & Co Inc., Sanofi SA, Takeda Pharmaceutical Company

Insomnia is a disorder characterized by lack of sleep or inability to sleep. People with insomnia often experience fatigue, low energy, difficulty concentrating, mood disturbances, and decreased performance overall. Insomnia-related conditions are caused due to disruption in circadian rhythm, chronic pain, hyperthyroidism, menopause, and psychological stress. Excessive use of drugs, such as caffeine, alcohol, and nicotine could also lead to insomnia.

Surging number of insomnia patient across the globe is the primary factor driving the market. Technological advances in the treatment drugs are also fuelling the target market growth currently. In addition, increasing number of people working in shifts and stressful conditions is also supporting the global market growth. However, lack of education and awareness about the disorder is a major restraining factor for the growth of the market. Factors like presence of large undiagnosed insomnia population pool and untapped markets in developing economies present lucrative opportunities for the market growth.

Global insomnia market has been segmented into therapy type drug formulation, and region.

On the basis of therapy type, global insomnia market has been bifurcated into pharmacological therapy and non pharmacological therapy. Non-pharmacological therapy is further segmented into hypnotherapy, cognitive behavioral therapy, medical devices, and other non-pharmacological therapy. Pharmacological therapy is further segmented into prescription sleep aids and over-the-counter sleep aids. Based on drug formulation, target market is classified into capsules and tablets. According to type of disease, global market is segmented into poor quality of sleep and sleep maintenance.

Download Free sample copy of this report @
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/239

Based on region, the global insomnia market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America region is dominating the global market as it accounts for the highest percentage of insomnia-affected patients among all regions. North America market is followed by Europe, owing to increasing stress among the population in these regions. Asia-Pacific, Middle East, and Africa markets are anticipated to have the least target market growth over the forecast period.

Key players operating in the global insomnia market include Eisai, Co., Pfizer, Inc., Merck & Co Inc., Sanofi SA, Takeda Pharmaceutical Company, Meda Consumer Healthcare Inc., Pernix Therapeutics, Purdue Pharma L.P., Consumer Healthcare Inc., and Dainippon Sumitomo Pharma Ltd.

Contact Us:
Mr Alex (Sales Manager)
Prophecy Market Insights
Phone: +91 777 504 9802
+1 860 531 2701
Email: sales@prophecymarketinsights.com

About us:
Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.

This release was published on openPR.